Mao et al. showed that the inhibition of the Notch signaling pathway is associated with reduced MDSCs, TAMs, and Tregs within emerging mouse tumor tissues, whereas the upregulation of the Notch1 downstream target, HES1, is significantly correlated with increased MDSCs, TAMs, and Tregs. This evidence concerns the gene NOTCH1 and neoplasm.